Browse Articles

Discover research articles across all indexed journals

Dual activation of NLRP3 and pyrin inflammasomes mediates host responses to the human fungal pathogen Coccidioides

Nature Communications Ka Pui Sharon Yau, Jonathan Rodrigo Erlich, Priscila Rodriguez et al. Jul 01, 2026 DOI: 10.1038/s41467-026-75022-8

Abstract Coccidioides is a dimorphic fungal pathogen that grows as a mold in soil and produces infectious arthroconidia. Inhaled arthroconidia transition to spherules containing endospores in mammalian hosts. How distinct developmental forms of Coccidioides interact with immune cells remains poorly defined. Here, we show that arthroconidia activates TLR2 and induces NLRP3-pyrin inflammasomes in macrophages, while ferroptotic signaling promotes arthroconidia killing. Upon transition to spherules, only ruptured spherules—not intact ones—trigger IL-1β production through NLRP3-pyrin inflammasomes and GSDMD-GSDME pores. A TLR2-NLRP3-pyrin-IL-18 axis in macrophages promotes spherule growth. Endospores activate NLRP3 but not pyrin inflammasomes. Caspase-1-deficient mice show improved disease tolerance to coccidioidomycosis despite equivalent fungal burdens, correlating with enhanced neutrophil extracellular trap formation in lung granulomas. Neutrophils respond to spherules through NLRP3-pyrin inflammasomes, GSDMD-GSDME, and MLKL. Together, these findings reveal that Coccidioides morphotypes elicit distinct yet overlapping immune programs, coordinating inflammasome activation and regulated cell death to shape host-pathogen dynamics.

Predicting Internal Versus External Nanoparticle Formation in Zr-Based Metal–Organic Frameworks

Journal of the American Chemical Society Zhaomin Su, Yuhang Song, Yibin Jiang et al. Jul 01, 2026 DOI: 10.1021/jacs.6c05556

Monotherapy or combinations? Intravenous vitamin C in sepsis and septic shock: An umbrella review of 31 systematic reviews

PLoS ONE Víctor Juan Vera-Ponce, Jhosmer Ballena-Caicedo, Lupita Ana Maria Valladolid-Sandoval et al. Jul 01, 2026 DOI: 10.1371/journal.pone.0351072

Intravenous (IV) vitamin C has been proposed as an adjuvant therapy in sepsis/septic shock due to its biological plausibility and safety profile, but the proliferation of reviews has not resolved its clinical utility. To synthesize the evidence on IV vitamin C (monotherapy, HAT—hydrocortisone+vitamin C+thiamine—and vitamin C+thiamine) in adults with sepsis/septic shock, prioritizing 28–30-day mortality. Umbrella review of systematic reviews and meta-analyses (MEDLINE/PubMed, Embase, Scopus, and Web of Science, without language restriction). Quality was assessed with AMSTAR 2, overlap with CCA, and when available, TSA and component/network meta-analysis (CINeMA). Certainty of evidence was graded using GRADE with an anchor estimator per outcome and regimen. Thirty-one reviews were included (30 quantitative: 28 SR/MA and 2 component/network MA; 1 qualitative). Combinations (HAT and vitamin C+thiamine) did not reduce mortality; hemodynamic improvements (small decreases in ΔSOFA and vasopressor hours) were modest, did not translate into survival benefits, and were primarily attributable to the corticosteroid. Monotherapy showed a possible mortality benefit signal under specific conditions (initiation ≤24 h, intermediate dose 25–100 mg/kg/day, 3–4-day courses; more pronounced in sepsis than shock), but with low-to-moderate certainty due to heterogeneity, imprecision, publication bias, and very high overlap among reviews. Combination regimens (HAT and vitamin C plus thiamine) did not reduce mortality; hemodynamic improvements were modest, did not translate into survival benefits, and were primarily attributable to the corticosteroid component. For monotherapy, a possible mortality benefit signal was identified under specific conditions (initiation within 24 h, intermediate dose 25–100 mg/kg/day, 3–4-day courses, more pronounced in sepsis than shock), but overall certainty remains low-to-moderate due to heterogeneity, imprecision, publication bias, and very high overlap among reviews. These findings do not support routine use of IV vitamin C in any regimen; for monotherapy, the identified signal warrants rigorous multicenter trials in well-defined clinical scenarios before any recommendation can be made.

Rational Asymmetric Acceptor Engineering via Unidirectional Terminal π‐Extension and Optimizing Alkyl Branching Sites Affords a Binary Photovoltaic Efficiency of 20.7% by Suppressed Nonradiative Energy Loss

Advanced Materials Heng Zhang, Yaokai Li, Kangbo Sun et al. Jul 01, 2026 DOI: 10.1002/adma.73646

ABSTRACT Ingenious molecular engineering of small‐molecule acceptors (SMAs) with low nonradiative energy loss (Δ E 3 ) and enhanced exciton diffusion length ( L D ) to overcome the efficiency bottleneck of binary organic solar cells (OSCs) remains a critical challenge. Herein, a series of symmetric SMAs ( TC1‐F to TC4‐F ) with progressively outward‐shifted branching sites and asymmetric/symmetric counterparts ( A‐TC3‐F and TC3‐NF ) incorporating unidirectional/bidirectional naphthyl‐based terminals, are synthesized for efficient binary OSCs. The optimal 3ʳ d carbon branching site induces a distinct triclinic crystallographic system with closer π‐π stacking. Unidirectional naphthyl terminal‐based single‐crystal creates an unprecedented 2D lamellar network/3D interpenetrated packing that provides multidimensional charge‐transport pathways, which enabled an improved L D and electron mobility in A‐TC3‐F neat film. The A‐TC3‐F ‐based blends optimize film formation kinetics and exhibit superior ordered molecular stacking morphology, yielding faster charge transport. Consequently, the optimized A‐TC3‐F ‐based binary OSCs achieve a champion PCE of 20.70% and an ultralow Δ E 3 of 0.191 eV, setting a new benchmark for binary OSCs with asymmetric terminal‐based SMAs. Our systematic work highlights an innovative pathway for precisely tailoring the side‐chain branching position and a unidirectional terminal π‐extension strategy to optimize molecular packing, mitigate trade‐offs of device parameters, and boost benchmark PCE and minimal Δ E 3 of binary OSCs with asymmetric terminal‐based SMAs.

TIP60 promotes chemoresistance by limiting intracellular platinum accumulation and enhancing removal of cisplatin-DNA adducts

Journal of Biological Chemistry Akshay Hira, Michael P. Craig, Caroline McLaughlin et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113338

Tumor NK ligand profiles as predictors of allogenic NK cell therapy responsiveness.

Journal of Clinical Oncology Nam H. B. Tran, Na Ly Tran, My T. T. Ngo et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.80

80 Background: Although NK cells offer a versatile and safe therapeutic platform, the understanding of natural killer (NK) cell therapy remains limited, particularly regarding mechanisms underlying effective tumor targeting. For clinical use, target recognition and anti-tumor efficacy need to be improved. In this study, we analyzed the activating and inhibitory signal integration to predict tumor responsiveness to NK cell therapy. Methods: Gene expression data for 13 activating and 10 inhibitory NK ligands were obtained from 6,892 solid tumors, including lung, breast, colorectal, and stomach cancers from the TCGA TARGET cohorts, and normalized against non-cancerous tissues from the GTEx database. From these data, NK ligand combination that were specifically enriched in particular cancer types were identified. The tumor NK ligand expression profiles were further used to compute a NK sensitivity prognostic index by subtracting inhibitory from activating signals. This index was validated in vitro using cytotoxicity assays of 50 NK donors against 5 cancer cell lines with different prognostic indexes. Results: We identified distinct NK ligand combinations that were exclusively enriched in each cancer type: TIGIT high NKG2D neg PD1 neg (62.6% in lung adenocarcinoma), NKG2D high TACTILE high (79.3% in lung squamous cell carcinoma), CD59 high 2B4 high (58.8% in breast cancer), NKG2D high TIGIT low NKp44 neg (51.0% in colorectal cancer) and NKp30 high TIM3 high (69.1% in stomach cancer). Factors such as NK cell donor identity and single ligand expression levels did not associate with NK sensitivity. In contrast, the NK prognostic index derived from composite ligand expression strongly correlated with in vitro NK cell-mediated cytotoxicity (R 2 =0.86, p=0.02). SW620 cells, which exhibited the highest prognostic index, were the most sensitive to NK cell killing, whereas MDA-MB-231 cells, which had the lowest prognostic index, were the most resistant. Conclusions: NK ligand signatures and the derived tumor prognostic index may serve as biomarkers for predicting NK cell therapy response and help physicians better stratify patients for NK-based therapeutic approaches.

TGFβ-mediated overexpression of podoplanin serves as a potential diagnostic biomarker in acute promyelocytic leukemia.

Journal of Clinical Oncology Syed K. Hasan, Akash Maity Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.264

264 Background: Early diagnosis of acute promyelocytic leukemia (APL), driven by PMLRARA oncoprotein, is vital for survival, as delays can cause fatal coagulopathy without prompt all-trans retinoic acid and arsenic trioxide therapy. Although APL is diagnosed using microscopy, immunophenotyping, and FISH/PCR for PML-RARA, morphological overlap with AML-M5 and AML-M2 complicates identification. In resource-limited settings, unavailability or delays in FISH/PCR increase the risk of missed or late diagnosis with fatal outcomes. Podoplanin (PDPN), a glycoprotein overexpressed in APL cells, interacts with platelets to mediate thrombosis. Methods: We evaluated PDPN expression using RQ-PCR and flow cytometry in APL versus non-APL AML samples, validated with TCGA-LAML and BEATAML1.0 datasets. Transcriptional regulation was investigated through in silico promoter analysis and validated through chromatin immunoprecipitation (ChIP-qPCR), TGF-β1 stimulation, and pharmacological inhibition using luspatercept. Serum TGF-β1 levels were measured by ELISA. Results: PDPN mRNA and surface protein were significantly higher in APL than non-APL AML (p<0.0001). Diagnostic sensitivity and specificity were 80.7% and 71.43% by RQ-PCR, and 92.86% and 100% by flow cytometry, respectively. ChIP-qPCR confirmed SMAD binding to PDPN promoter, and TGF-β1 stimulation upregulated PDPN expression. Luspatercept reduced SMAD phosphorylation and PDPN expression, indicating TGF-β/SMAD transcriptionally regulates PDPN. APL patients exhibited significantly elevated serum TGF-β1 levels compared to non-APL AML (p<0.0001). Conclusions: PDPN overexpression results from TGF-β/SMAD signaling and represents a promising diagnostic biomarker for APL, particularly valuable where molecular testing is unavailable or delayed. Keywords: Acute Promyelocytic Leukemia (APL), Coagulopathy, Podoplanin, RQPCR, Flow cytometry, TGF-β.

Vegetation browning patterns under compound soil and atmospheric dryness in northern permafrost ecosystems

Nature Communications Mousong Wu, Oliver Sonnentag, Mark J. Lara et al. Jul 01, 2026 DOI: 10.1038/s41467-026-75131-4

Leveraging Stereochemistry to Optimize the Properties of Polyhydroxyalkanoates

Journal of the American Chemical Society Morgan S. Young, Yolanda Rusconi, Anne M. LaPointe et al. Jul 01, 2026 DOI: 10.1021/jacs.6c08149

Physics-informed gaussian process regression for reproducible and uncertainty-aware CO2 injectivity prediction

PLoS ONE Shamsuddeen Adamu, Hitham Alhussian, Said Jadid Abdulkadir et al. Jul 01, 2026 DOI: 10.1371/journal.pone.0352178

Reliable prediction of CO 2 injectivity decline is essential for safe geological carbon storage, yet existing machine learning models often provide deterministic point predictions that lack uncertainty quantification. This paper presents a physics-informed Gaussian process regression (PC-GPR) framework for Relative Injectivity Change (RIC) prediction, embedding constraints derived from two independently grounded physical laws: the Derjaguin–Landau–Verwey–Overbeek (DLVO) colloidal monotonicity condition and the Civan–Kozeny–Carman permeability impairment model. Four GP variants are developed and benchmarked on a curated laboratory dataset ( n  = 44) under a three-tier validation protocol combining Leave-One-Out cross-validation, repeated k -fold cross-validation, and non-parametric bootstrap confidence intervals. Two complementary uncertainty quantification mechanisms are employed: GP posterior calibration via the Expected Calibration Error (ECE) and split-conformal prediction intervals. The GP-Base model achieves strong predictive performance (LOO R 2  = 0.9401, 95% CI: [0.882, 0.978]) with well-calibrated uncertainty (ECE = 0.026) and reliable coverage (97.7% at the nominal 95% level). The PC-GPR-M variant reduces DLVO monotonicity violations to 1.5% across the input domain, demonstrating effective soft constraint enforcement. Operationally, the proposed framework translates predictive uncertainty into actionable injection scheduling guidance, identifying high-risk regions at salinity >30,000 ppm and jamming ratio >0.04. These results provide an uncertainty-aware baseline for future PIML research in subsurface carbon storage.

Regulating Electrostatic Discharge via Quasi‐gate Electrode for High‐Performance Direct‐current Triboelectric Nanogenerators

Advanced Materials Xiaochuan Li, Xuemei Zhang, Ren Dahu et al. Jul 01, 2026 DOI: 10.1002/adma.73659

ABSTRACT Direct‐current triboelectric nanogenerators (DC‐TENGs) are promising for mechanical energy harvesting but are often hindered by incomplete charge collection and parasitic discharge pathways. Herein, inspired by the operating characteristics of depletion‐mode field‐effect transistors, we propose a quasi‐gate‐electrode enhanced DC‐TENG (QGED‐TENG). The QGED‐TENG employs a back‐side quasi‐gate‐electrode (QGE) and porous polytetrafluoroethylene film to modulate electrostatic breakdown and charge leakage, thereby effectively suppressing parasitic discharge. The QGED‐TENG enables direction‐contingent enhancement and depletion modes without external bias, notably delivering a 1.41‐fold output charge increase in enhancement mode compared to the device without the QGE. Furthermore, by leveraging redistributed electric fields and parallel discharge pathways, the multi‐unit architecture achieves a linear charge increase relative to the number of units. Benefiting from the synergistic effects of electrostatic breakdown, charge leakage, and electric field redistribution within the multi‐unit configuration, an optimized rotational QGED‐TENG achieved an ultrahigh average power density of 25 W m −2 Hz −1 and an output charge density of 13.65 mC m −2 at 60 rpm, setting a new benchmark for the porous triboelectric layer of electrostatic breakdown‐based DC‐TENGs. This work provides new physical insights and a general design strategy for maximizing spatial charge utilization and enabling high output performance DC‐TENG.

Oleoylethanolamide enhances regulatory T Cell function to accelerate plaque regression in atherosclerosis via PPARα activation

Journal of Biological Chemistry Tong Ren, Yanchao Jiao, Le Zhang et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113236

Admission-day predictors of terminal outcome in advanced cancer inpatients: Insights from a large Indian palliative care cohort.

Journal of Clinical Oncology Allwin Jesuraj, Seema Mishra, Rakesh Garg et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.339

339 Background: Inpatient mortality in palliative care units ranges 10-30% globally, yet prognostic data from low- and middle-income countries (LMICs) remain limited. Whether admission-day clinical and laboratory variables can identify high-risk patients in resource-limited settings is unclear. Methods: Retrospective analysis of a prospectively maintained database from two inpatient palliative care wards at a tertiary cancer centre in North India. All consecutive index admissions (January-December 2025) were included. Primary outcome: terminal event (inpatient death or discharge for end-of-life home-based care). Predictors: ECOG performance status, admission reason, number of complaints, serum albumin, haemoglobin, estimated glomerular filtration rate, total leukocyte count, age, sex, weekend admission, cancer type, distance. Multivariable logistic regression with stepwise selection identified independent predictors. Sensitivity analysis examined mortality alone. Results: Among 1,458 patients (mean age 52.3±14.1 years, 51% male), terminal events occurred in 275 (18.9%) and deaths in 182 (12.5%). Multivariable analysis retained 6 independent predictors (Table). ECOG PS 4 showed strongest association (OR 42.3). Symptom-based predictors included dyspnoea (OR 33.8), delirium (OR 23.3), and symptom complexity with ≥3 complaints (OR 17.1). Laboratory markers included severe renal impairment (OR 3.3) and albumin (OR 0.55 per g/dL, protective). Weekend admission was associated with increased risk (OR 2.5). Sensitivity analysis using mortality alone yielded consistent findings. Conclusions: Basic admission day variables can reliably forecast terminal outcomes among palliative care inpatients. ECOG PS, initial symptoms, albumin, and kidney function, all accessible at the bedside without advanced tests, help guide triage, care planning, and resource distribution in LMICs. The results encourage early prognosis discussions and care preparation. Independent admission-day predictors of terminal event in palliative care inpatients (n=1458). Predictor OR (95% CI) P-value ECOG PS 4 (vs 1-2) 42.3 (17.8 - 100.6) <0.001 Dyspnoea (vs pain) 33.8 (8.7 - 132.1) <0.001 Delirium (vs pain) 23.3 (5.9 - 92.6) <0.001 ≥3 complaints (vs 0-1) 17.1 (3.5 - 83.2) <0.001 Severe CKD (vs normal) 3.3 (1.8 - 6.1) <0.001 Weekend admission 2.5 (1.4 - 4.4) 0.002 Albumin (per g/dL) 0.55 (0.39 - 0.76) <0.001

Yttrium-90 resin microsphere transarterial radioembolization in unresectable hepatocellular carcinoma: Early results with scout dose–based lung shunt estimation and dosimetry.

Journal of Clinical Oncology Jasim Jaleel, Bharadwaj S. Mangu, Amar Mukund et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.155

155 Background: Yttrium-90 TARE is an effective locoregional therapy for HCC. TARE traditionally requires 99mTc-MAA for lung shunt fraction (LSF) estimation. Our hospital lacked a functional gamma camera, which made 99mTc-MAA imaging impossible. We aimed to report our initial results using scout Y-90 for LSF estimation, dosimetry planning and interim treatment response. Methods: Between May 2025 and January 2026, forty four consecutive patients were evaluated for Y-90 TARE. After injection of the Y-90 scout dose, PET/CT images were acquired, and LSF and lung dose (LD) calculations were performed using MIM-SurePlan Y90 dosimetry software. Patients with excessive LSF were excluded. Post-therapy PET/CT scans were performed to assess the distribution and dosimetry of the Y-90 microspheres. Treatment response was evaluated using LIRADS and RECIST 1.1 criteria on follow-up triple-phase computed tomography. Results: Of the 44 patients, four were excluded owing to increased LSF (>20%), and two were diagnosed with intrahepatic cholangiocarcinoma. Of the remaining 38 HCC patients, six underwent streamlined TARE without LSF estimation, and the remaining 32 patients received standard scout dose–based dosimetry-guided treatment. The mean activity of the scout dose administered was 0.5 GBq (SD - 0.1). The mean pre-therapy LSF was 4.9 %, with a corresponding mean pre-therapy LD of 6.7 Gy. The mean treatment activity of Y-90 delivered was 3.27 GBq (SD-1.4) with a mean delivered tumor dose of 350.2 Gy (SD-165). The mean post-therapy LSF was 4.0 % with a corresponding LD of 5.4 Gy. A good correlation was observed between pre- and post-therapy LSF (r = 0.79, p < 0.01) and LD (r = 0.84, p < 0.01). At the time of analysis, follow-up imaging was available for 24 patients, demonstrating that 17 of them showed a complete response (LR-TR nonviable), 6 showed partial response (LR-TR viable), and one showed stable disease, resulting in an objective response rate (ORR) of 95.8%. Early adverse effects included fatigue, abdominal pain, nausea, vomiting, chest pain and fever, which were self-limiting. Four patients developed radiation-induced lung injury, and two developed acute liver failure. Conclusions: Y-90 TARE with pretreatment scout dose-based LSF estimation and individualized dosimetry is safe and feasible in real-world tertiary care practice. The encouraging ORR and correlation between pre- and post-therapy LSF and LD support the robustness of the dosimetry approach.

Isopentane Disproportionation in Lewis Acidic Chloroaluminate Ionic Liquid

Journal of the American Chemical Society Jiande Mai, David E. Ryan, Wei Zhang et al. Jul 01, 2026 DOI: 10.1021/jacs.6c03060

Revisiting fatty acid-mediated antibody purification from plasma with insights into selectivity and protein integrity

PLoS ONE Sirisak Sathorn, Garnpimol C. Ritthidej, Wanatchaporn Arunmanee Jul 01, 2026 DOI: 10.1371/journal.pone.0352679

Therapeutic antibodies play an essential role in modern biopharmaceuticals, with polyclonal antibodies (pAbs) remaining indispensable for applications such as toxin and virus neutralization. However, pAb purification is complicated by serum-derived contaminants. Selective impurity precipitation using caprylic acid (C8) or sodium caprylate (NaC8) provides an effective strategy for obtaining high-purity antibody preparations and serves as a low-cost, scalable non-chromatographic alternative. However, the influence of fatty acid chain length and ionic form on differential precipitation remains poorly understood. Here, we systematically evaluated free fatty acids with varying chain length (C8–C10) and their corresponding sodium salts for pAb purification. Using model proteins, free fatty acids exhibited greater selectivity than their salt forms, and precipitation efficiency decreased with increasing chain length (C8 > C9 > C10). Importantly, C9 at 2% (v/v) provided a favorable balance between impurity removal and γ-globulin retention, achieving effective depletion of albumin while minimizing antibody loss relative to conventional C8 precipitation. Multi-spectroscopic analyses confirmed that γ-globulin maintained its native structure following fatty acid–based precipitation. When applied to the fractionation of IgG from hyperimmunized equine plasma, C9 achieved impurity reduction and IgG homogeneity comparable to conventional C8 treatment while preserving antigen-binding avidity. Collectively, these findings identify C9 as a selective and function-preserving precipitant with potential as an efficient and scalable pretreatment step in polyclonal antibody purification workflows.

Integrated Local‐Microstructure Engineering Toward Mechanochemically Robust Ultra‐High Nickel Cathodes

Advanced Materials Zhouyue Li, Yike Jin, Ning Qin et al. Jul 01, 2026 DOI: 10.1002/adma.73673

ABSTRACT Ni‐rich layered cathodes show exceptional promise for next‐generation high‐energy‐density lithium‐ion batteries. However, higher nickel utilization in layered cathodes readily exacerbates both bulk mechanical failure and interfacial chemistry instability, significantly hindering their practical application. Herein, a comprehensive local lattice regulation strategy was proposed via Mg/Nb co‐doping, which constructed a chemically and mechanically co‐robust LiNi 0.95 Co 0.03 Mn 0.02 O 2 cathode from surface to bulk. The surface‐reconstructed ultrathin disordered rock‐salt phase effectively stabilized the electrochemical interface. Meanwhile, the bulk cation‐disordered structure integrated with a coherent spinel‐like phase mitigated lattice strain and enhanced structural integrity. Therefore, the modified ultra‐high nickel cathode exhibited excellent long‐term cycling stability, high rate capability, and thermal stability. It exhibited high initial coulombic efficiency of 93.24% and a discharge specific capacity of 240.11 mAh·g −1 at 0.1C. It could also deliver a high initial capacity of 210.44 mAh·g −1 at 1C and retain 97.37% of its capacity after 100 cycles. Moreover, it exhibited outstanding performance during cycling at 3C, delivering a superior capacity retention of 81.65% after 500 cycles. It also delivered a remarkable specific capacity of 147.43 mAh·g −1 even at the rate of 15C. This integrated microstructure regulation strategy would pave the way for commercializing ultra‐high‐nickel cathodes in next‐generation high‐energy‐density batteries.

Dysregulated HELLS expression alters cellular processes and serves as a potential prognostic marker in acute myeloid leukemia

Journal of Biological Chemistry Swati Madhulika, T Sayamsmruti Panda, Priyanka Samal et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113210

Hepatic arterial infusion chemotherapy combined with camrelizumab and lenvatinib in the treatment of advanced hepatocellular carcinoma: A retrospective study.

Journal of Clinical Oncology Wei Dong, Zhuoni Huo, Haoran Zhao et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.98

98 Background: PD-1 inhibitors combined with tyrosine kinase inhibitors have achieved encouraging efficacy in unresectable hepatocellular carcinoma (HCC). Hepatic arterial infusion chemotherapy (HAIC) with FOLFOX regimen has also shown promising response and survival benefits for advanced HCC. This study retrospectively analyzed the efficacy and safety of HAIC plus camrelizumab and lenvatinib in advanced HCC. Methods: Patients with advanced HCC who received ≥3 cycles of HAIC combined with camrelizumab and lenvatinib at Harbin Medical University Cancer Hospital from November 2020 to February 2023 were included. Baseline characteristics, treatment detail, tumor response, survival outcomes, and adverse events (AEs) were analyzed. Results: Sixty-four patients received HAIC plus camrelizumab and lenvatinib. Twenty-two (34.4%) were converted to resectable disease: 16 underwent hepatectomy, 1 received radiofrequency ablation, and 5 declined surgery. By mRECIST, 9 patients achieved complete response, 33 partial response, 16 stable disease, and 6 progressive disease, yielding an overall response rate (ORR) of 65.6%. By RECIST v1.1, the ORR was 59.4%. With a median follow-up of 47.8 months, median overall survival (OS) was not reacheds. The 1-, 2-, 3-, and 4-year OS rates were 87.2%, 70.4%, 60.2%, and 56.0%, respectively. Patients who underwent curative resection or ablation (n=17) had significantly longer OS than those without curative treatment (P<0.05). Median progression-free survival (PFS) for all patients was 19.3 months; 1-, 2-, 3-, and 4-year PFS rates were 69.0%, 34.4%, 20.7%, and 20.7%, respectively. For the 17 patients receiving curative treatment, median event-free survival (EFS) was not reached, with 1-, 2-, 3-, and 4-year EFS rates of 79.3%, 61.7%, 52.9%, and 52.9%, respectively. Patients achieving an objective response by mRECIST showed a trend toward improved OS (P=0.053). All patients experienced treatment-related AEs. Common AEs included constipation (98.4%), abdominal pain (98.4%), nausea (82.8%), hyperbilirubinemia (60.9%), elevated AST (69.4%), elevated ALT (57.8%), neutropenia (57.8%), leukopenia (51.6%), thrombocytopenia (46.9%), lymphopenia (43.8%), anemia (40.6%), increased γ-GT (39.1%), and hypothyroidism (10.9%). Grade 3-4 AEs included neutropenia (31.3%), lymphopenia (15.6%), hyperbilirubinemia (12.5%), elevated AST (7.8%), elevated γ-GT (7.8%), leukopenia (6.3%), elevated ALT (4.7%), thrombocytopenia (3.1%), anemia (1.6%), hypothyroidism (1.6%), and rash (1.6%). Conclusions: HAIC combined with camrelizumab and lenvatinib showed manageable toxicity and substantial antitumor activity in advanced HCC. The high response rate and 34.4% conversion to resectability suggest this triple regimen is a promising strategy for conversion therapy and long-term disease control.

Redefining ·CO <sub>3</sub> <sup>–</sup> Formation Chemistry: Zundel-like Switches Drive Carbonate-·OH Interfacial Reactivity

Journal of the American Chemical Society Jiarong Liu, Xiaohua Yang, Jinkai Gu et al. Jul 01, 2026 DOI: 10.1021/jacs.6c01510